Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hyperoxia
(fraction of inspired oxygen = 95%) induces death of lung epithelial cells. The duration of cell survival in the setting of
hyperoxia
depends on
hyperoxia
-induced activation of intracellular survival pathways. Two survival pathways with known effects on lung epithelial cells are the propidium iodide 3-kinase/Akt and extracellular signal-regulated kinase (ERK)/mitogen-activated protein (MAP) kinase pathways. We investigated the effect of
hyperoxia
on activity of both the Akt and ERK pathways in the A549 lung epithelial cell line.
Hyperoxia
-exposed cells show progressive loss of Akt activation and total Akt protein.
Hyperoxia
decreases Akt mRNA, consistent with the loss of total Akt. In addition,
hyperoxia
induces ERK activation. Inhibition of ERK with the
MAP kinase kinase 1
/2 inhibitor, U0126, shortens the survival time of cells in
hyperoxia
, suggesting that increased ERK activity partially compensates for the
hyperoxia
-induced Akt downregulation. Our findings show, for the first time, that
hyperoxia
has divergent effects on two survival pathways (Akt and ERK), and that ERK activity compensates for the loss of the Akt survival effects, delaying the death of
hyperoxia
-exposed lung epithelial cells.
...
PMID:Extracellular signal-regulated kinase activation delays hyperoxia-induced epithelial cell death in conditions of Akt downregulation. 1530 7